Investigating brain resilience in the context of AD, these residual methods regressed MRI-based measures of brain structure, such as hippocampal volumes18 and cortical thickness,15 onto CSF biomarkers of β-amyloid18 and tau.15,18. This evidence concerns the gene MAPT and Alzheimer disease.